Latest results from JULIET: Tisagenlecleucel in adults with DLBCL

Bookmark and Share
Published: 1 Dec 2018
Views: 596
Dr Richard Maziarz - Oregon Health & Science Knight Cancer Institute, Portland, USA

Dr Richard Maziarz speaks to ecancer at ASH 2018 about tisagenlecleucel in adults with relapsed and refractory treatment-resistant diffuse large B-cell lymphoma (DLBCL).

Watch his interview with ecancer here.

Read the article about this work here.